Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jong Hyun | - |
dc.contributor.author | Wang, Min | - |
dc.contributor.author | Lee, Jaehun | - |
dc.contributor.author | Park, Han-Jin | - |
dc.contributor.author | Han, Chungseong | - |
dc.contributor.author | Hong, Hee Su | - |
dc.contributor.author | Kim, Jeong Seong | - |
dc.contributor.author | An, Geun Ho | - |
dc.contributor.author | Park, Kijung | - |
dc.contributor.author | Park, Hee-Kyung | - |
dc.contributor.author | Zhu, Shi Feng | - |
dc.contributor.author | Sun, Xiao-Bo | - |
dc.contributor.author | Kim, Jong-Hoon | - |
dc.contributor.author | Woo, Dong-Hun | - |
dc.date.accessioned | 2021-09-02T15:57:30Z | - |
dc.date.available | 2021-09-02T15:57:30Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-02 | - |
dc.identifier.issn | 0742-2091 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/77888 | - |
dc.description.abstract | Drug-induced liver toxicity is a main reason for withdrawals of new drugs in late clinical phases and post-launch of the drugs. Thus, hepatotoxicity screening of drug candidates in pre-clinical stage is important for reducing drug attrition rates during the clinical development process. Here, we show commercially available hepatocytes that could be used for early toxicity evaluation of drug candidates. From our hepatic differentiation technology, we obtained highly pure (>= 98%) hepatocytes from human embryonic stem cells (hESCs) having mature phenotypes and similar gene expression profiles with those of primary human tissues. Furthermore, we optimized 96-well culture condition of hESC-derived hepatocytes suitable for toxicity tests in vitro. To this end, we demonstrated the efficacy of our optimized hepatocyte model for predicting hepatotoxicity against the Chinese herbal medicines and showed that toxicity patterns from our hepatocyte model was similar to those of human primary cultured hepatocytes. We conclude that toxicity test using our hepatocyte model could be a good alternative cell source for pre-clinical study to predict potential hepatotoxicity in drug discovery industries. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER | - |
dc.subject | METABOLIZING-ENZYMES | - |
dc.subject | SIGNALING PATHWAYS | - |
dc.subject | GENE-EXPRESSION | - |
dc.subject | LIVER-INJURY | - |
dc.subject | RECEPTOR | - |
dc.subject | RAT | - |
dc.subject | ACID | - |
dc.subject | PXR | - |
dc.subject | TROGLITAZONE | - |
dc.subject | SENSITIVITY | - |
dc.title | Prediction of hepatotoxicity for drugs using human pluripotent stem cell-derived hepatocytes | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jong-Hoon | - |
dc.identifier.doi | 10.1007/s10565-017-9392-y | - |
dc.identifier.scopusid | 2-s2.0-85017171294 | - |
dc.identifier.wosid | 000422983600005 | - |
dc.identifier.bibliographicCitation | CELL BIOLOGY AND TOXICOLOGY, v.34, no.1, pp.51 - 64 | - |
dc.relation.isPartOf | CELL BIOLOGY AND TOXICOLOGY | - |
dc.citation.title | CELL BIOLOGY AND TOXICOLOGY | - |
dc.citation.volume | 34 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 51 | - |
dc.citation.endPage | 64 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalResearchArea | Toxicology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Toxicology | - |
dc.subject.keywordPlus | METABOLIZING-ENZYMES | - |
dc.subject.keywordPlus | SIGNALING PATHWAYS | - |
dc.subject.keywordPlus | GENE-EXPRESSION | - |
dc.subject.keywordPlus | LIVER-INJURY | - |
dc.subject.keywordPlus | RECEPTOR | - |
dc.subject.keywordPlus | RAT | - |
dc.subject.keywordPlus | ACID | - |
dc.subject.keywordPlus | PXR | - |
dc.subject.keywordPlus | TROGLITAZONE | - |
dc.subject.keywordPlus | SENSITIVITY | - |
dc.subject.keywordAuthor | Drug screening | - |
dc.subject.keywordAuthor | Hepatocytes | - |
dc.subject.keywordAuthor | Human embryonic stem cells | - |
dc.subject.keywordAuthor | Toxicity test | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.